Alejandro Nicola Candia

10PUBLICATIONS
31CO-AUTHORS
Molecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Medical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 26, 2025
Integrated Workflow for Drug Repurposing in Glioblastoma: Computational Prediction and Preclinical Validation of Therapeutic Candidates.

Nazareno Gonzalez, Melanie Pérez Küper, Matías Garcia Fallit

|Sep 28, 2023
Targeting FOXP3 Tumor-Intrinsic Effects Using Adenoviral Vectors in Experimental Breast Cancer.

Alejandro J Nicola Candia, Matías Garcia Fallit, Jorge A Peña Agudelo

|Aug 26, 2023
Mitochondrial Peptide Humanin Facilitates Chemoresistance in Glioblastoma Cells.

Jorge A Peña Agudelo, Matías L Pidre, Matias Garcia Fallit

|Jun 28, 2023
In Vitro and In Vivo Efficacy of a Stroma-Targeted, Tumor Microenvironment Responsive Oncolytic Adenovirus in Different Preclinical Models of Cancer.

Ana Alfano, Eduardo G A Cafferata, Mariela Gangemi

|Dec 14, 2021
Potential of IDH mutations as immunotherapeutic targets in gliomas: a review and meta-analysis.

Nazareno Gonzalez, Antonela S Asad, José Gómez Escalante

|Sep 08, 2020
The role of the prolactin receptor pathway in the pathogenesis of glioblastoma: what do we know so far?

Antonela S Asad, Alejandro J Nicola Candia, Nazareno Gonzalez

Pageof 2

Frequent Collaborators

6 joint publications

Marianela Candolfi

5 joint publications

Adriana Seilicovich

5 joint publications

Antonela Sofia Asad

4 joint publications

Camila Zuccato